Neela Therapeutics, Inc. — Form D/A
Neela Therapeutics, Inc. of LUNENBURG, MA, a company, filed a Form D amendment with the SEC on 2026-05-26. The offering totals $21.5M, of which $13.8M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2026-05-26
- Form: D/A
- Accession: 0002090797-26-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $21.5M
- Amount sold: $13.8M
- Remaining: $7.7M
- Investors: 21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-564918
Issuer
- Name: Neela Therapeutics, Inc.
- CIK: 0002090797
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 96 ROBBS HILL ROAD, LUNENBURG, MA, 01462
- Phone: 781-929-6094
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| PJ Anand | Related Person | Lowell, MA |
| David Donabedian | Related Person | Lowell, MA |
| Edgar D. Jannotta Jr. | Related Person | LUNENBURG, MA |
| Stephen Oesterle | Related Person | Lowell, MA |
| Norbert Riedel | Related Person | LUNENBURG, MA |
| Richard Upton | Related Person | Lowell, MA |
| David Donabedian | Director | Lowell, MA |
| Cameron Durrant | Director | Lowell, MA |
| Richard Upton | Director | Lowell, MA |
| Edgar D Jannotta Jr. | Director | LUNENBURG, MA |
| PJ Anand | Director | Lowell, MA |
| PJ Anand | Executive Officer | Lowell, MA |
| Norbert Riedel | Director | LUNENBURG, MA |
| Stephen D Oesterle | Director | SCOTTSDALE, AZ |
Other filings by this issuer (1)
More